Thiago de Matos Dourado

CV Lattes

Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. Escola Paulista de Medicina (EPM) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Thiago de Matos Dourado in research grants and scholarships supported by FAPESP.

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Completed (most recent)

Abstract
Highly Active Antiretroviral Therapy (HAART) has been shown great results. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are widely used as first-line therapy. In Brazil, the therapy comprises the first-generation NNRTIs, nevirapine, and efavirenz, and also the second-generation NNRTI, etravirine. These drugs change the HIV-1 reverse transcriptase conformation, an alteration th…
Analysis of HIV-1 minority populations resistant to the non-nucleoside reverse transcriptase inhibitor (NNRTI) etravirine among patients infected with HIV-1 resistant to the NNRTIs nevirapine and efavirenz, BP.IC

Virtual Library in numbers * Updated data on July 26, 2025

Total / Available in English

1 / 1	Completed scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Ricardo Sobhie Diaz

Keywords used by the researcher

Biological Sciences Microbiology

Please report errors on the page using this form.

Short URL

Abstract